Advertisement
Screener

Statera Biopharma, Inc. Increase (Decrease) in Employee Related Liabilities

Statera Biopharma, Inc. Increase (Decrease) in Employee Related Liabilities

Statera Biopharma, Inc. reported Increase (Decrease) in Employee Related Liabilities of $643.88 thousand for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-09.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities · last filed 2013-05-09

  • Statera Biopharma, Inc. increase (decrease) in employee related liabilities for the quarter ending 2013-03-31 was $643.88K, a 22.00% decline year-over-year.
  • Statera Biopharma, Inc. increase (decrease) in employee related liabilities for the quarter ending 2012-09-30 was -$326.21K, a 182.27% decline year-over-year.
  • Statera Biopharma, Inc. increase (decrease) in employee related liabilities for the quarter ending 2012-06-30 was $1.11M.
  • Statera Biopharma, Inc. increase (decrease) in employee related liabilities for the quarter ending 2012-03-31 was $825.48K.
  • Statera Biopharma, Inc. increase (decrease) in employee related liabilities for fiscal 2011 was -$243.22K, a 475.28% decline from fiscal 2010.
  • Statera Biopharma, Inc. increase (decrease) in employee related liabilities for fiscal 2010 was $64.81K, a 75.46% decline from fiscal 2009.
  • Statera Biopharma, Inc. increase (decrease) in employee related liabilities for fiscal 2009 was $264.14K.
Period endIncrease (Decrease) in Employee Related Liabilities 3 monthIncrease (Decrease) in Employee Related Liabilities 6 monthIncrease (Decrease) in Employee Related Liabilities 6 month as first filedIncrease (Decrease) in Employee Related Liabilities 9 monthIncrease (Decrease) in Employee Related Liabilities 9 month as first filedIncrease (Decrease) in Employee Related Liabilities 12 month
2013-03-31$643.88K
10-Q · filed 2013-05-09
2012-09-30-$326.21K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09
$783.89K
derived: sum of 2 quarters · filed 2012-11-09
$1.61M
10-Q · filed 2012-11-09
$1.20M
derived: sum of 4 quarters · filed 2013-05-09
2012-06-30$1.11M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09
$1.94M
10-Q · filed 2012-08-09
$1.52M
derived: sum of 3 quarters · filed 2013-05-09
$1.92M
derived: sum of 4 quarters · filed 2013-05-09
2012-03-31$825.48K
10-Q · filed 2013-05-09
$412.20K
derived: sum of 2 quarters · filed 2013-05-09
$808.70K
derived: sum of 3 quarters · filed 2013-05-09
2011-12-31-$413.27K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-13
-$16.78K
derived: sum of 2 quarters · filed 2012-11-09
-$243.22K
10-K · filed 2012-03-13
2011-09-30$396.49K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09
$170.06K
10-Q · filed 2012-11-09
-$328.95K
10-Q · filed 2011-11-09
2011-06-30-$226.44K
10-Q · filed 2012-08-09
-$3.32M
10-Q · filed 2011-08-09
2010-12-31$64.81K
derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-13
$64.81K
derived: sum of 2 quarters · filed 2012-03-13
$64.81K
10-K · filed 2012-03-13
2010-09-30$0.00
derived: 10-Q/A 9 month − 10-Q 6 month · filed 2011-11-14
$0.00
10-Q/A · filed 2011-11-14
2010-06-30$0.00
10-Q · filed 2011-08-09
2009-12-31$264.14K
10-K · filed 2012-03-13